Adi Mor
Chief Executive Officer chez CHEMOMAB THERAPEUTICS LTD.
Fortune : 22 132 $ au 31/03/2024
Profil
Adi Mor is the founder.
She founded Chemomab Ltd.
in 2011, where she holds the title of Director, Chief Executive & Scientific Officer.
She also founded Chemomab Therapeutics Ltd.
in 2011, where she holds the title of Chief Executive Officer & Director.
Dr. Mor obtained a doctorate degree from Tel-Aviv University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
28/03/2024 | 568 222 ( 0,27% ) | 22 132 $ | 31/03/2024 |
Postes actifs de Adi Mor
Sociétés | Poste | Début |
---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Chief Executive Officer | 01/06/2023 |
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Chief Executive Officer | 01/01/2011 |
Formation de Adi Mor
Tel-Aviv University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Health Technology |